Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- CheckyesterdayChange DetectedThe page revision badge updated from v3.5.4 to v3.5.5. This indicates a new revision of the page content or metadata for the study record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, representing a new version of the page. This is a metadata-level update rather than a change to study-specific information.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s displayed revision/version has been updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded glossary term: Mucopolysaccharidosis, MPS-II. Removed glossary term: Mucopolysaccharidosis type 2.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows Revision: v3.5.0. The previous Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.